Skip to Main Content
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT



Property Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
Advertisement
European Journal of Internal Medicine
Close
  • Home
  • Articles and Issues
    • Back
    • Articles in Press
    • Current Issue
    • List of Issues
  • Free Collections
    • Back
    • Editors Choice
    • Internal Medicine Flashcards
    • Choice of COVID-19 Vaccines
  • For Authors
    • Back
    • About Open Access 
    • Author Information
    • Researcher Academy 
    • Submit Your Manuscript 
  • Journal Info
    • Back
    • About Open Access 
    • About the Journal
    • Abstracting/Indexing
    • Career Opportunities 
    • Contact Information
    • Editorial Board
    • Advertising 
    • New Content Alerts
    • Pricing
  • Calendar of Events
  • Subscribe
  • Society Information
  • More Periodicals
    • Back
    • Find a Periodical 
    • Go to Product Catalog 
Advanced searchSave search

Please enter a term before submitting your search.

Ok
  • Submit
  • Log in
  • Register
  • Log in
    • Submit
    • Log in
  • Subscribe
  • Claim
Skip menu

    Login to your account

    Show
    Forgot password?
    Don’t have an account?
    Create a Free Account

    If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

    If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

    Cancel
    x

    Filter:

    Filters applied

    • Choice of COVID-19 Vaccines
    • European Journal of Internal MedicineRemove European Journal of Internal Medicine filter
    Clear all

    Article Type

    • Letter2
    • Discussion1

    Publication Date

    • Last 5 Years3
    Please choose a date range between 2021 and 2021.

    Author

    • Dal-Ré, Rafael2
    • Banzi, Rita1
    • Betsch, Cornelia1
    • Eitze, Sarah1
    • Korn, Lars1
    • Siegers, Regina1
    • Sprengholz, Philipp1
    • Sreeharan, Nadarajah1
    • Stephens, Richard1

    Keyword

    • COVID-192
    • Administration1
    • AstraZeneca vaccine1
    • Autonomy1
    • Covid-191
    • elderly1
    • emergency authorization1
    • Hesitancy1
    • MHRA1
    • SARS-CoV-21
    • UK1
    • Vaccination hesitancy1
    • Vaccine allocation1
    • Vaccines1

    Access Filter

    • Open Access

    Collection: Choice of COVID-19 Vaccines

    3 Results
    Subscribe to collection
    • Export
      • PDF
      • Citation

    Please select at least one article in order to proceed.

    Ok
    FilterHide Filter
    • Letter to the Editor

      The power of choice: Experimental evidence that freedom to choose a vaccine against COVID-19 improves willingness to be vaccinated

      European Journal of Internal Medicine
      Vol. 87p106–108Published online: March 18, 2021
      • Philipp Sprengholz
      • Sarah Eitze
      • Lars Korn
      • Regina Siegers
      • Cornelia Betsch
      Cited in Scopus: 12
      • Preview Hide Preview
      • Download PDF
      • Export Citation
        Ending the COVID-19 pandemic will require rapid and large-scale uptake of vaccines against the disease. The European Commission has authorized three vaccines so far, and first doses have already been delivered and administered across Europe [5]. However, patients cannot usually choose between vaccines, and Dal-Ré, Stephens and Sreeharan [4] argued in their recent letter to the Editor that restricting freedom of choice may increase vaccination hesitancy, threatening uptake and the achievement of herd immunity.
        The power of choice: Experimental evidence that freedom to choose a vaccine against COVID-19 improves willingness to be vaccinated
      • Commentary

        When is it reasonable to extrapolate during a pandemic?: The case of broad UK labeling for AstraZeneca COVID-19 vaccine

        European Journal of Internal Medicine
        Vol. 87p1–2Published online: March 18, 2021
        • Rafael Dal-Ré
        • Rita Banzi
        Cited in Scopus: 2
        • Preview Hide Preview
        • Download PDF
        • Export Citation
          Amid an unprecedented surge of COVID-19 cases in the UK, with an increasing number due to a novel more infectious SARS-CoV-2 variant,[1] the UK regulatory agency (MHRA) granted emergency approval to the AstraZeneca COVID-19 vaccine on 30 December 2020. The target population includes adults and elderly. The posology consisting of two separate doses given 4-12 weeks apart. Almost simultaneously, the UK health authorities recommended a dose interval of 12 weeks for both COVID-19 authorized vaccines (Pfizer/BioNTech; AstraZeneca), due to the shortage of doses and to vaccinate the highest number of citizens.
        • Letter to the Editor

          “Let me choose my COVID-19 vaccine”

          European Journal of Internal Medicine
          Vol. 87p104–105Published online: February 3, 2021
          • Rafael Dal-Ré
          • Richard Stephens
          • Nadarajah Sreeharan
          Cited in Scopus: 13
          • Preview Hide Preview
          • Download PDF
          • Export Citation
            In the first half of 2021, many millions of Europeans will be offered vaccination against SARS -CoV-2. Four vaccines, two mRNA-based vaccines (Pfizer-BioNTech and NIH-Moderna) and two non-replicating viral vector-based vaccines (Oxford-AstraZeneca and Janssen) will likely be available through national health services (NHS). Should citizens accept the vaccine provided by their NHS or should they have the option of selecting the vaccine of their choice?
          Page 1 of 1
          • Home
          • Articles and Issues
          • Articles in Press
          • Current Issue
          • List of Issues
          • Free Collections
          • Editors Choice
          • Internal Medicine Flashcards
          • Choice of COVID-19 Vaccines
          • For Authors
          • About Open Access
          • Author Information
          • Researcher Academy
          • Submit Your Manuscript
          • Journal Info
          • About Open Access
          • About the Journal
          • Abstracting/Indexing
          • Career Opportunities
          • Contact Information
          • Editorial Board
          • Advertising
          • New Content Alerts
          • Pricing
          • Calendar of Events
          • Subscribe
          • Society Information
          • More Periodicals
          • Find a Periodical
          • Go to Product Catalog
          We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
          Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.

          • Privacy Policy  
          • Terms and Conditions  
          • Accessibility  
          • Help & Contact

          RELX